Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$2.54(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$2.54High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2025-12-15PLX
Pluxee
Pravin GondhaleBarclays$13.36$16.50+23.50%Equal Weight
2025-11-10PLX
Pluxee
Pravin GondhaleBarclays$15.51$20.00+28.95%Equal Weight
2025-09-16PLX
Pluxee
Pravin GondhaleBarclays$14.54$21.00+44.43%Equal Weight
2024-09-11PLX
Pluxee
Pravin GondhaleBarclays$18.97$26.00+37.06%Equal Weight
2024-02-01PLX
Pluxee
Pravin GondhaleBarclays$29.91$28.00-6.39%Equal Weight

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95